Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
99 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- "medizinische Universität Graz "
Graz, Austria
- "medizinische Universität Innsbruck Univ.-Klinik Für Innere Medizin V"
Innsbruck, Austria
- "ordensklinikum Linz Barmherzige Schwestern Interne I"
Linz, Austria
- "landeskrankenhaus Feldkirch Interne E"
Rankweil, Austria
- "landeskrankenhaus (salk) Universitätsklinik Für Innere Medizin Iii (salk)"
Salzburg, Austria
- "allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung Für Onkologie"
Vienna, Austria
- "landesklinikum Wiener Neustadt "
Wiener Neustadt, Austria
- "olv Ziekenhuis Oncology"
Aalst, Belgium
- "universitair Ziekenhuis Antwerpen Oncologie"
Edegem, Belgium
- "uz Leuven Campus Gasthuisberg Digestieve Oncologie"
Leuven, Belgium
- "chc Montlégia Oncologie"
Liège, Belgium
- "az Nikolaas Oncology"
Sint-Niklaas, Belgium
- "hospital Do Câncer de Barretos - Fundação Pio Xii Unidade de Pesquisa Clínica"
Barretos, Brazil
- "hospital de Base Centro Integrado de Pesquisa"
São José do Rio Preto, Brazil
- "icesp - Instituto Do Câncer Do Estado de São Paulo Centro Integrado de Pesquisa"
São Paulo, Brazil
- Hospital A C Camargo Unidade de Pesquisa Clinica Rua Antonio Prudente
São Paulo, Brazil
- Hospital Albert Einstein Instituto de Ensino E Pesquisa Av Albert Einstein
São Paulo, Brazil
- Hospital Sao Camilo Nucleo de Pesquisa Av Alcantara Machado
São Paulo, Brazil
- "aalborg Universitetshospital, Syd Onkologisk Afdeling"
Aalborg, Denmark
- Rigshospitalet Dpt of Oncology
Copenhagen, Denmark
- "regionshospitalet Herning, Hospitalsenheden Vest Onkologisk Afdeling"
Herning, Denmark
- "odense Universitetshospital Department of Oncology"
Odense, Denmark
- "chu Jean Minjoz Service D'Oncologie Médicale"
Besançon, France
- "chu Morvan Institut de Cancérologie Et D'Hématologie"
Brest, France
- "centre de Lutte Contre Le Cancer Francois Baclesse Ucp Digestif"
Caen, France
- "hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-Oncologie Digestive"
Paris, France
- Hôpital Saint-Antoine Service D'Oncologie Médicale
Paris, France
- Chu de Poitiers Pole Régional de Cancérologie
Poitiers, France
- Charite Universitätsmedizin Medizinische Klinik M.S. Haemat., Onko., Tumorimmunologie
Berlin, Germany
- Onkologische Schwerpunktpraxis Kurfuerstendamm
Berlin, Germany
- Lübecker Onkologische Schwerpunktpraxis Im Hochschulstadttei
Lübeck, Germany
- Klinikum Der Universität München Campus Großhadern, Medizinische Klinik Und Poliklinik Iii
München, Germany
- Magyar Honvedseg Egeszsegugyi Kozpont Onkologiai Osztaly
Budapest, Hungary
- Szent Imre Egyetemi Oktatokorhaz Klinikai Onkologiai Osztaly
Budapest, Hungary
- Debreceni Egyetem Orvos Es Egeszsegtudomanyi Centrum Onkologiai Intezet
Debrecen, Hungary
- Petz Aladar Megyei Oktato Korhaz Onkoradiologiai Osztaly
Győr, Hungary
- Bacs-Kiskun Megyei Korhaz Onkoradiologiai Kozpont
Kecskemét, Hungary
- Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kp. Onkoterápiás Klinika
Szeged, Hungary
- Jnsz Megyei Hetenyi Geza Korhaz Es Rendelointezet Megyei Onkologiai Centrum
Szolnok, Hungary
- Markusovszky Egyetemi Oktatokorhaz Onkoradiologiai Osztaly
Szombathely, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Nov 2020
- Primary completion
- 19 Jul 2022
- Completion
- 12 Sept 2023
- Last update posted
- 24 Sept 2024
- Registered enrollment
- 492
- Registry id
- NCT04737187
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.